- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
North Korea Claims to have cure for AIDS, MERS, EBOLA and many more
Where the greatest scientists of the world have failed, North Korea seems to have succeeded. The dictator run nation claims that it has developed a drug that can cure deadly diseases including MERS, EBOLA, SARS, Aids and even cancers.The official Korean Central News Agency (KCNA) said scientists have developed a wonder drug using various rare-earth elements that can cure...
The official Korean Central News Agency (KCNA) said scientists have developed a wonder drug using various rare-earth elements that can cure many diseases.
“Malicious virus infections like Sars, Ebola and Mers are diseases that are related to immune systems, so they can be easily treated by Kumdang-2 injection drug, which is a strong immune reviver,” KCNA said.
Although there is no proof, the drug’s website cites a medical study in Africa where HIV positive patients are claimed to be cured with the drug. The claims comes as Rival and neighbor South Korea has been struggling with the disease of MERS.
This is not the first time that the country has come up with bizarre claims. Similar claims of the same drug were made earlier during bird flu outbreaks in 2006 and 2013.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country.She is a member of the Association of Healthcare Journalists. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751